Index stratifies risk for advanced colorectal neoplasia

August 12, 2015
Index stratifies risk for advanced colorectal neoplasia

(HealthDay)—A scoring system can stratify risk for advanced colorectal neoplasia in asymptomatic adults, according to a study published online Aug. 11 in the Annals of Internal Medicine.

Thomas F. Imperiale, M.D., from the Indiana University School of Medicine in Indianapolis, and colleagues conducted a cross-sectional study to create a risk index for advanced neoplasia anywhere in the colorectum, using the most common risk factors for . Data were included for persons aged 50 to 80 years undergoing initial screening colonoscopy.

The researchers found that the prevalence of advanced neoplasia was 9.4 percent among 2,993 persons in the derivation set. For people classified as being at very low, low, intermediate, and high risk, the risks for advanced neoplasia were 1.92, 4.88, 9.93, and 24.9 percent, respectively (P < 0.001). In the low-risk groups, sigmoidoscopy to the descending colon would have detected 73 percent of advanced neoplasms. The corresponding risks for advanced neoplasia were 1.65, 3.31, 10.9, and 22.3 percent, respectively, among the 1,467 persons in the validation set (P < 0.001). Sigmoidoscopy would have detected 87.5 percent of advanced neoplasms.

"The score may be useful in counseling average-risk patients about their risk for ," writes the author of an accompanying editorial. "But until stronger scientific evidence is available, I would not recommend such scores for choosing the type of screening test an average-risk person should have."

Explore further: Factors ID'd for CRC risk stratification with positive FIT

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Factors ID'd for CRC risk stratification with positive FIT

September 12, 2014
(HealthDay)—Fecal hemoglobin concentration, sex, and age can be used to classify the risk of advanced colorectal neoplasia among individuals with positive results from fecal immunochemical tests (FITs), according to a study ...

'Scoring system' may spot those in greatest need of colonoscopy

August 11, 2015
(HealthDay)— Colonoscopy can save lives, but experts agree that testing rates remain too low. Now, researchers say a special scoring system might point to those people at highest risk for colon cancer, who may need the ...

Review: weak power in most CRC neoplasia risk prediction models

October 14, 2014
(HealthDay)—Most colorectal neoplasia risk prediction models have weak discriminatory power, according to a review published in the October issue of Clinical Gastroenterology and Hepatology.

Support for fecal testing in familial colorectal cancer screening

October 29, 2014
Fecal immunochemical tests (FIT) may be as effective as colonoscopies when it comes to detecting colorectal cancer among first-degree relatives of patients with colorectal cancer, according to a new study in Gastroenterology, ...

Recommended for you

DNA vaccine leads to immune responses in HPV-related head and neck cancer

September 21, 2018
A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus (HPV)-related head and neck cancer. Researchers from the Abramson Cancer Center of the University of ...

In zebrafish, a way to find new cancer therapies, targeting tumor modulators

September 21, 2018
The lab of Leonard Zon, MD, at Boston Children's Hospital has long been interested in making blood stem cells in quantity for therapeutic purposes. Looking for a way to test for their presence in zebrafish, their go-to research ...

What can salad dressing tell us about cancer? Think oil and vinegar

September 20, 2018
Researchers led by St. Jude Children's Research Hospital scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as prostate and breast cancer. The ...

Novel biomarker found in ovarian cancer patients can predict response to therapy

September 20, 2018
Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but ...

Testing fluorescent tracers used to help surgeons determine edges of breast cancer tumors

September 20, 2018
A team of researchers with members from institutions in The Netherlands and China has conducted a test of fluorescent tracers meant to aid surgeons performing tumor removal in breast cancer patients. In their paper published ...

Cancer immunotherapy might benefit from previously overlooked immune players

September 20, 2018
Cancer immunotherapy—efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own—has shown great promise for some previously intractable cancers. Yet immunotherapy doesn't work ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.